On August 8, 2024 Aclaris Therapeutics had Daily Balance Of Power of (0.33). Balance of Power indicator (or BOP) measures the strength of Aclaris Therapeutics market sensitivity to bulls and bears. It estimates the ability of Aclaris Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Aclaris Therapeutics Balance of Power indicator one can determine a trend of the price direction.
On August 09 2024 Aclaris Therapeutics was traded for 1.16 at the closing time. The top price for the day was 1.19 and the lowest listed price was 1.15 . The trading volume for the day was 431.2 K. The trading history from August 9, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.85% . The overall trading delta against the current closing price is 2.56% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Other Forecasting Options for Aclaris Therapeutics
For every potential investor in Aclaris, whether a beginner or expert, Aclaris Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aclaris Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aclaris. Basic forecasting techniques help filter out the noise by identifying Aclaris Therapeutics' price trends.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aclaris Therapeutics stock to make a market-neutral strategy. Peer analysis of Aclaris Therapeutics could also be used in its relative valuation, which is a method of valuing Aclaris Therapeutics by comparing valuation metrics with similar companies.
Aclaris Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Aclaris Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Aclaris Therapeutics' current price.
Market strength indicators help investors to evaluate how Aclaris Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aclaris Therapeutics shares will generate the highest return on investment. By undertsting and applying Aclaris Therapeutics stock market strength indicators, traders can identify Aclaris Therapeutics entry and exit signals to maximize returns.
The analysis of Aclaris Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aclaris Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aclaris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.